Although we still wonder whether the interaction mechanism between Notch3 and β-catenin signaling is the same as that of Notch1, we can determine the mechanism of action that clarifies the coordination of multiple signaling pathways to better target CSCs in the treatment of HCC. This evidence concerns the gene NOTCH3 and hepatocellular carcinoma.